Moreover, we found that MPO‐induced chemokine receptor expression is the driving mechanism for increased cardiac monocyte infiltration after myocardial infarction; therefore, we believe that dual therapy using MPO and chemokine receptor inhibition can be considered an anti‐inflammatory treatment for ischemic heart disease. This evidence concerns the gene MPO and coronary artery disorder.